← The Wire
PVLANasdaq
PALVELLA THERAPEUTICS, INC.
Pharmaceutical Preparations · NV · CIK 1583648
Develops and commercializes novel therapies for rare skin diseases and vascular malformations
red 8-K · 90d
$1.56B
Market cap
$154.84
Last close
+4.5%
1D
+30.3%
5D
324K
Volume
Price · last 39 sessions+21.3%
May 4L $102.19 · H $154.84Jun 29
345
Total filings
Jun 16, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 16, 20268-KCompany UpdateMay 20, 20268-KCompany UpdateMay 15, 20268-KCompany UpdateMay 13, 20268-KResults of Operations · Reg FD DisclosureMay 7, 202610-Q10-QMay 7, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 30, 20268-KExecutive ChangeApr 13, 20268-KCompany UpdateApr 7, 202610-K10-KMar 31, 20268-KResults of Operations · Reg FD DisclosureMar 31, 20268-KMaterial AgreementFeb 26, 2026424B5424B5Feb 26, 2026424B5424B5Feb 24, 20268-KResults of OperationsFeb 24, 20268-KReg FD DisclosureFeb 24, 20268-KCompany UpdateFeb 24, 20268-KCompany UpdateJan 29, 20268-KCompany UpdateJan 12, 20268-KReg FD Disclosure · Company UpdateDec 15, 202510-Q10-QNov 12, 20258-KResults of Operations · Reg FD DisclosureNov 10, 20258-KReg FD Disclosure · Company UpdateNov 5, 20258-KReg FD DisclosureSep 24, 20258-KReg FD DisclosureSep 3, 202510-Q10-QAug 14, 20258-KResults of Operations · Reg FD DisclosureAug 14, 20258-KShareholder VoteJun 11, 202510-Q10-QMay 15, 20258-KResults of Operations · Reg FD DisclosureMay 15, 2025DEFA14ADEFA14AApr 30, 2025DEF 14AFORM DEF 14AApr 30, 202510-K10-KMar 31, 20258-KResults of Operations · Reg FD DisclosureMar 31, 20258-KReg FD DisclosureMar 4, 2025S-1/AFORM S-1/AJan 14, 20258-KReg FD DisclosureJan 13, 2025S-1FORM S-1Dec 31, 20248-KChange of Control · Executive ChangeDec 16, 2024425FORM 425Dec 12, 20248-KExecutive Change · Security-Holder RightsDec 12, 2024425FORM 425Dec 3, 20248-KShareholder Vote · Company UpdateDec 3, 202410-QFORM 10-QNov 13, 2024425FORM 425Nov 7, 2024DEF 14AFORM DEF 14ANov 6, 2024425FORM 425Oct 17, 2024425FORM 425Oct 15, 2024425FORM 425Oct 3, 20248-KCompany UpdateOct 3, 202410-QFORM 10-QAug 14, 2024S-4FORM S-4Aug 9, 2024425FORM 425Aug 8, 20248-KMaterial Agreement · Equity IssuanceAug 8, 2024SC 13GSC 13GAug 1, 2024425FORM 425Jul 24, 20248-KExecutive Change · Material AgreementJul 24, 20248-KAgreement Terminated · Company UpdateJul 3, 2024SC 13GTHE SCHEDULE 13GMay 17, 2024SC 13GTHE SCHEDULE 13GMay 17, 202410-QFORM 10-QMay 15, 20248-KCompany UpdateMay 9, 202410-K/AFORM 10-K/AApr 29, 20248-KSecurity-Holder Rights · Bylaw AmendmentApr 18, 202410-KFORM 10-KMar 29, 20248-KResults of Operations · Company UpdateMar 27, 20248-KAgreement TerminatedDec 21, 202310-QFORM 10-QNov 14, 20238-K/AExit / Disposal CostsAug 31, 202310-QFORM 10-QAug 10, 20238-KAgreement Terminated · Results of OperationsJul 18, 20238-KExecutive ChangeJul 13, 20238-KExecutive Change · Shareholder VoteJun 26, 20238-KResults of Operations · Company UpdateJun 21, 2023SC 13GSC 13GJun 12, 20238-KReg FD DisclosureJun 8, 2023SC 13DSCHEDULE 13DMay 22, 20238-KDelisting NoticeMay 19, 202310-QFORM 10-QMay 11, 2023
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 18, 2026: 2 insiders bought $800K · 1 sold $1.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Goin KathleenChief Operating Officer | Sell | 2,268 | $117.56 | $267K |
| Mar 18, 2026 | Goin KathleenChief Operating Officer | Sell | 1,730 | $118.37 | $205K |
| Mar 18, 2026 | Goin KathleenChief Operating Officer | Sell | 304 | $119.08 | $36K |
| Feb 27, 2026 | Jenkins George MDirector | Buy | 4,000 | $125.00 | $500K |
| Feb 27, 2026 | Heron Elaine JDirector | Buy | 2,400 | $125.00 | $300K |
| Feb 18, 2026 | Goin KathleenChief Operating Officer | Sell | 3,026 | $79.16 | $240K |
| Feb 18, 2026 | Goin KathleenChief Operating Officer | Sell | 1,276 | $79.97 | $102K |
| Jan 21, 2026 | Goin KathleenChief Operating Officer | Sell | 3,749 | $97.94 | $367K |
| Jan 21, 2026 | Goin KathleenChief Operating Officer | Sell | 553 | $95.49 | $53K |
| Dec 17, 2025 | Goin KathleenChief Operating Officer | Sell | 4,302 | $96.47 | $415K |
| Nov 19, 2025 | Goin KathleenChief Operating Officer | Sell | 2,802 | $86.51 | $242K |
| Nov 19, 2025 | Goin KathleenChief Operating Officer | Sell | 1,500 | $85.72 | $129K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance